Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

被引:8
|
作者
Zeiser, Robert
Burchert, Andreas
Lengerke, Claudia
Verbeek, Mareike
Maas-Bauer, Kristina
Metzelder, Stephan
Spoerl, Silvia
Ditschkowski, Markus
Ecsedi, Matyas
Sockel, Katja
Ayuk, Francis
Salem, Ajib
de Fontbrune, Flore Sicre
Na, Il-Kang
Livius, Penter
Holtick, Udo
Wolf, Dominik
Schuler, Esther
Meyer, Everett
Apostolova, Petya
Bertz, Hartmut
Marks, Reinhard
Lubbert, Michael
Wasch, Ralph
Scheid, Christof
Stolzel, Friedrich
Ordemann, Rainer
Bug, Gesine
Kobbe, Guido
Shah, Omid
Negrin, Robert S.
Brune, Mats
Spyridonidis, Alexandros
Schmitt-Graeff, Annette
van der Velden, Walter J. F. M.
Huls, Gerwin
Mielke, Stephan
Grigoleit, Goetz Ulrich
Kuball, Jurgen
Flynn, Ryan P.
Ihorst, Gabriele
Du, Jing
Blazar, Bruce R.
Arnold, Renate
Kroger, Nicolaus
Passweg, Jakob R.
Halter, Joerg
Socie, Gerard
Beelen, Dietrich W.
Peschel, Christian
机构
关键词
D O I
10.1182/blood.V128.22.4561.4561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4561
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients
    Zeiser, Robert
    Burchert, Andreas
    Lengerke, Claudia
    Verbeek, Mareike
    Maas-Bauer, Kristina
    Metzelder, Stephan
    Spoerl, Silvia
    Ditschkowski, Markus
    Ecsedi, Matyas
    Sockel, Katja
    Ayuk, Francis
    Ajib, Salem
    de Fontbrune, Flore Sicre
    Na, Il-Kang
    Penter, Livius
    Holtick, Udo
    Wolf, Dominik
    Schuler, Esther
    Meyer, Everett
    Apostolova, Petya
    Bertz, Hartmut
    Marks, Reinhard
    Luebbert, Michael
    Waesch, Ralph M.
    Scheid, Christof
    Stoelzel, Friedrich
    Ordemann, Rainer
    Bug, Cesine
    Kobbe, Guido
    Negrin, Robert
    Brune, Mats L.
    Spyridonidis, Alexandros
    Schmitt-Graeff, Annette
    van der Velden, Walter
    Huls, Gerwin
    Mielke, Stephan
    Grigoleit, Goetz Ulrich
    Kuball, Jurgen
    Flynn, Ryan P.
    Ihorst, Gabriele
    Du, Jing
    Blazar, Bruce R.
    Arnold, Renate
    Kroeger, Nicolaus
    Halter, Joerg
    Socie, Gerard
    Beelen, Dietrich
    Pesche, Christian, I
    Neubauer, Andreas
    Finke, Juergen
    BLOOD, 2015, 126 (23)
  • [2] Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease
    Assouan, Deborah
    Lebon, Delphine
    Charbonnier, Amandine
    Royer, Bruno
    Marolleau, Jean-Pierre
    Gruson, Berengere
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (05) : 687 - 689
  • [3] Long-term follow-up of ruxolitinib for therapy in corticosteroid refractory chronic graft-versus-host disease: A single center-experience
    Sanli, N. Mandaci
    Karakus, E.
    Keklik, M.
    Unal, A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 205 - 205
  • [4] Long-Term Follow-Up of Ruxolitinib in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease
    Ferreira, Aliana Meneses
    Szor, Roberta Shcolnik
    Molla, Vinicius Campos
    Seiwald, Maria Cristina
    de Moraes, Pedro Arruda
    Brito Medeiros da Fonseca, Ana Rita
    Xavier, Erick Menezes
    Serpa, Mariana Gomes
    Tucunduva, Luciana
    Novis, Yana
    Arrais-Rodrigues, Celso
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 777.e1 - 777.e6
  • [5] Ruxolitinib for corticosteroid-refractory graft-versus-host disease: analysis of 95 patients treated at multiple medical centers
    Zeiser, R.
    Burchert, A.
    Lengerke, C.
    Verbeek, M.
    Maas-Bauer, K.
    Metzelder, S.
    Spoerl, S.
    Ditschkowski, M.
    Ecsedi, M.
    Sockel, K.
    Ayuk, F.
    Ajib, S.
    de Fontbrune, Sicre F.
    Na, I. -K
    Penter, L.
    Holtick, U.
    Wolf, D.
    Schuler, E.
    Meyer, E.
    Apostolova, P.
    Bertz, H.
    Marks, R.
    Luebbert, M.
    Waesch, R.
    Scheid, C.
    Ordemann, R.
    Bug, G.
    Kobbe, G.
    Negrin, R.
    Brune, M.
    Spyridonidis, A.
    Schmitt-Graeff, A.
    van der Velden, W.
    Huls, G.
    Grigoleit, G. U.
    Kuball, J.
    Blazar, B. R.
    Arnold, R.
    Kroeger, N.
    Passweg, J.
    Halter, J.
    Socie, G.
    Beelen, D.
    Peschel, C.
    Neubauer, A.
    Finke, J.
    Duyster, J.
    von Bubnoff, N.
    Oncology Research and Treatment, 2015, 38 : 43 - 44
  • [6] Long-Term Follow-up of Ruxolitinib in Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease (GVHD)
    Ferreira, Aliana Meneses
    Molla, Vinicius Campos
    Seiwald, Maria Cristina Nunez
    Szor, Roberta Shcolnik
    De Moraes, Pedro Henrique Arruda
    Da Fonseca, Ana Rita
    Serpa, Mariana
    Xavier, Erick Menezes
    Tucunduva, Luciana
    Novis, Yana
    Arrais-Rodrigues, Celso
    BLOOD, 2020, 136
  • [7] Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease
    Mayer, J
    Krejcí, M
    Doubek, M
    Pospísil, Z
    Brychtová, Y
    Tomíska, M
    Rácil, Z
    BONE MARROW TRANSPLANTATION, 2005, 35 (07) : 699 - 705
  • [8] Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease
    J Mayer
    M Krejčí
    M Doubek
    Z Pospíšil
    Y Brychtová
    M Tomíška
    Z Ráčil
    Bone Marrow Transplantation, 2005, 35 : 699 - 705
  • [10] High response rates in patients treated with ruxolitinib for corticosteroid-refractory Graft-versus-host disease: analysis including 13 Transplant Centers
    Zeiser, R.
    Lengerke, C.
    Spoerl, S.
    Maas-Bauer, K.
    Ditschkowski, M.
    Ecsedi, M.
    Sockel, K.
    Ayuk, F.
    Sicre-de-Fontbrune, F.
    Na, I-K
    Ajib, S.
    Verbeek, M.
    Nogai, H.
    Holtick, U.
    Wolf, D.
    Schuler, E.
    Meyer, E.
    Apostolova, P.
    Illert, L.
    Bertz, H.
    Marks, R.
    Waesch, R.
    Hackanson, B.
    Scheid, C.
    Ordemann, R.
    Bug, G.
    Kobbe, G.
    Negrin, R.
    Arnold, R.
    Kroeger, N.
    Passweg, J.
    Halter, J.
    Socie, G.
    Beelen, D.
    Finke, J.
    Peschel, C.
    Duyster, J.
    von Bubnoff, N.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S22 - S22